Revvity | 普通股股本

股票价格
104.49
每天变化
1.67 1.62%
每月一次
0.58%
每年
-7.22%
Q1 预测
98.47


金融业
股票价格
USD
资产
USD 12.17B
现金及等价物
USD 919.86M
销售成本
USD 350.4M
流动资产
USD 2.24B
流动负债
USD 1.33B
债务
USD 3.37B
股息收益率
0.29
EBIT
USD 145.83M
EBITDA
USD 248.91M
员工
11K
EPS每股收益
USD 1.7
股本和储备
USD 7.38B
销售毛利
USD 421.66M
债务利息支出
USD 23.51M
利息收入
USD 0.4
贷款资金
USD 2.63B
市值
USD 12.77B
净收入
USD 98.36M
营业费用
USD 626.22M
营业利润
USD 145.83M
普通股股本
USD 113.38M
PE价格收益
USD 49.87
税前利润
USD 55.68M
销售收入
USD 772.06M
销售和管理费用
USD 251.73M
股票
USD 379.5M
贸易债权人
USD 185.46M
应收帐款人
USD 744.67M


普通股股本 更改 日
Agilent USD 283.05M 540K 2025-09
Align Technology USD 71.75M 736K 2025-12
Bio Techne USD 155.75M 154.18M 2025-09
Bio-Rad Laboratories USD 27.06M 571K 2025-06
Bruker USD 151.72M 149.92M 2025-09
Celltrion KRW 218.78M 1.5M 2025-09
Charles River Laboratories USD 49.22M 6K 2025-09
Cspc Pharmaceutical CNY 11.52B 486M 2025-06
Danaher USD 706.9M 600K 2025-12
Dentsply International USD 199.5M 196.5M 2025-09
Dianthus Therapeutics USD 42.85M 42.82M 2025-09
Divis Laboratories Ltd INR 265.47M 264.53M 2025-09
Edwards Lifesciences USD 580.7M 7.2M 2025-09
Exact Sciences USD 189.45M 232K 2025-09
Hologic USD 222.57M 350K 2025-09
Illumina USD 152.8M 900K 2025-12
Intuitive Surgical USD 354.5M 3.98M 2025-12
IQVIA Holdings USD 169.6M 700K 2025-12
Kangmei Pharma CNY 13.86B 0 2025-06
Knight Therapeutics CAD 539.32M 1.63M 2024-09
Laboratorios Farma EUR 51.82M 1.55M 2023-12
Laboratory Of America USD 82.9M 75.3M 2025-06
Malin Corporation EUR 200K 0 2024-12
Medical Developments International AUD 115.01M 9.28M 2024-12
Mesa Laboratories USD 349.53M 3.53M 2024-09
Mettler Toledo International USD 20.43M 170.6K 2025-12
Myriad Genetics USD 93.1M 0 2025-09
Neuren Pharmaceuticals AUD 165.27M 10.43M 2024-12
OraSure Technologies USD 0 0 2024-06
Organigram Holdings CAD 134.46M 438.86K 2025-09
Pacific Biosciences Of California USD 258K 8K 2023-09
Pharma Mar EUR 17.58M 0 2025-09
Qiagen NV USD 216.56M 284.67K 2025-12
Quest Diagnostics USD 111M 1000K 2025-09
Quidel USD 67.9M 200K 2025-09
Repligen USD 56.28M 30K 2025-09
Revvity USD 113.38M 2.7M 2025-12
Sartorius EUR 69.04M 0 2025-09
Sino Biopharmaceutical CNY 17.89B 30.5M 2025-06
Thermo Fisher Scientific USD 375.71M 1.9M 2025-12
Tilray USD 1.06B 86.93M 2025-03
Waters USD 98.08M 38.55M 2025-12
Zz Pientze Pharmaceu CNY 603.32M 0 2025-09


Revvity 普通股股本 - 当前值，历史数据，预测，统计，图表和经济日历 - Feb 2026.